NASDAQ · Analyst Forecast

NeoGenomics, Inc. (NEO) Stock Forecast & Price Target

$15.25 NASDAQ: NEO Market Cap $1.99B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering NeoGenomics, Inc. (NEO), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For NeoGenomics, Inc., analysts forecast revenue rising from 725.65M in 2025 to 1.11B in 2030; the average estimate for 2030 earnings per share is 0.81; with published estimates ranging from 0.80 to 0.81; 9 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$15.25
Consensus targetThe average of the price targets analysts have published.$22.60
Median targetThe middle target, less affected by a single outlier.$22.00
Highest targetThe most optimistic published target.$28.00
Lowest targetThe most pessimistic published target.$19.00
Difference from priceHow far the consensus target sits from today’s price.+48.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (reporting currency)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025723.89M725.65M727.11M8
2026807.57M808.20M808.57M8
2027882.61M888.03M890.89M9
2028956.03M971.97M982.82M8
20291.02B1.03B1.03B6
20301.10B1.11B1.12B6

Earnings per share forecast

YearLowAverageHighAnalysts
20250.080.090.118
20260.190.200.218
20270.300.310.339
2028−0.100.400.878
20290.680.690.696
20300.800.810.816

NeoGenomics, Inc. (NEO) forecast — frequently asked questions

What is the analyst price target for NeoGenomics, Inc.?

Analysts covering NeoGenomics, Inc. (NEO) have a consensus price target of $22.60, 48.2% above the current price of $15.25. Published targets range from $19.00 to $28.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for NeoGenomics, Inc.'s earnings?

The average analyst estimate for NeoGenomics, Inc. (NEO) earnings per share in 2030 is 0.81, with individual estimates between 0.80 and 0.81.

How much revenue is NeoGenomics, Inc. expected to make?

Analysts forecast NeoGenomics, Inc. (NEO) revenue of 1.11B in 2030, based on 6 published estimates.

How many analysts cover NEO?

9 analysts contribute estimates for NeoGenomics, Inc. (NEO). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Diagnostics & Research stocks

TMO forecastDHR forecastIDXX forecastA forecastWAT forecastIQV forecastNTRA forecastMTD forecastILMN forecastLH forecastAll Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.